| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.31 | 0.02 |